Justin Sharim1, Wei-Lun Lo2, Won Kim3, Srinivas Chivukula3, Stephen Tenn4, Tania Kaprealian4, Nader Pouratian5. 1. David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California. 2. Department of Neurosurgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; Division of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan; Doctoral Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan. 3. Department of Neurosurgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California. 4. Department of Radiation Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California. 5. Department of Neurosurgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; Department of Radiation Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; Brain Research Institute, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; Neuroscience Interdepartmental Program, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California. Electronic address: npouratian@mednet.ucla.edu.
Abstract
PURPOSE: Stereotactic radiosurgery (SRS) provides a noninvasive treatment modality for patients with medically refractory trigeminal neuralgia. The root entry zone (REZ) has been proposed to be an ideal stereotactic target because it is partially composed of centrally produced myelin, conferring a theoretical increased sensitivity to irradiation as well as increased susceptibility to neurovascular conflict, making it the site in which nociceptive signals likely arise. The aim of this study is to determine if there is a statistically and clinically significant difference in pain relief or facial hypesthesia following SRS based on distance of the stereotactic isocenter from REZ. METHODS AND MATERIALS: Patients undergoing Novalis radiosurgery for the treatment of trigeminal neuralgia with at least 3 months' follow-up were included in this study. Postoperative outcomes were stratified by Barrow Neurological Institute (BNI) score for pain relief and BNI facial numbness score for facial hypesthesia. RESULTS: Sixty-seven patients met inclusion criteria and were included in this study. BNI score of I-IIIa was attained in 82% of patients at 3 months and 65% at 1 year following SRS. Distance from isocenter to REZ varied from 0 to 8.6 mm, with a mean of 1.94 ± 1.62 mm. Logistic regression of target-REZ distance against pain relief outcome (patients with score I-IIIa and IIIb-V) was insignificant at 3 months (P = .988), 6 months (P = .925), 9 months (P = .845), and 12 months (P = .547) postoperatively. Furthermore, no significant correlation was found with logistic regression of target-REZ distance with pain relief outcome (patients with score I and score II-IV) (P = .544). CONCLUSIONS: The current analysis suggests that distance from REZ does not correlate with degree of postoperative pain relief or facial hypesthesia; thus, targeting specific regions within the trigeminal nerve in relation to these anatomical characteristics may not afford any advantage from this perspective.
PURPOSE: Stereotactic radiosurgery (SRS) provides a noninvasive treatment modality for patients with medically refractory trigeminal neuralgia. The root entry zone (REZ) has been proposed to be an ideal stereotactic target because it is partially composed of centrally produced myelin, conferring a theoretical increased sensitivity to irradiation as well as increased susceptibility to neurovascular conflict, making it the site in which nociceptive signals likely arise. The aim of this study is to determine if there is a statistically and clinically significant difference in pain relief or facial hypesthesia following SRS based on distance of the stereotactic isocenter from REZ. METHODS AND MATERIALS: Patients undergoing Novalis radiosurgery for the treatment of trigeminal neuralgia with at least 3 months' follow-up were included in this study. Postoperative outcomes were stratified by Barrow Neurological Institute (BNI) score for pain relief and BNI facial numbness score for facial hypesthesia. RESULTS: Sixty-seven patients met inclusion criteria and were included in this study. BNI score of I-IIIa was attained in 82% of patients at 3 months and 65% at 1 year following SRS. Distance from isocenter to REZ varied from 0 to 8.6 mm, with a mean of 1.94 ± 1.62 mm. Logistic regression of target-REZ distance against pain relief outcome (patients with score I-IIIa and IIIb-V) was insignificant at 3 months (P = .988), 6 months (P = .925), 9 months (P = .845), and 12 months (P = .547) postoperatively. Furthermore, no significant correlation was found with logistic regression of target-REZ distance with pain relief outcome (patients with score I and score II-IV) (P = .544). CONCLUSIONS: The current analysis suggests that distance from REZ does not correlate with degree of postoperative pain relief or facial hypesthesia; thus, targeting specific regions within the trigeminal nerve in relation to these anatomical characteristics may not afford any advantage from this perspective.
Authors: C L Rogers; A G Shetter; J A Fiedler; K A Smith; P P Han; B L Speiser Journal: Int J Radiat Oncol Biol Phys Date: 2000-07-01 Impact factor: 7.038
Authors: Bryan W Goss; Leonardo Frighetto; Antonio A F DeSalles; Zachary Smith; Timothy Solberg; Michael Selch Journal: Neurosurgery Date: 2003-10 Impact factor: 4.654
Authors: Nicolas Massager; José Lorenzoni; Daniel Devriendt; Françoise Desmedt; Jacques Brotchi; Marc Levivier Journal: J Neurosurg Date: 2004-04 Impact factor: 5.115
Authors: Aldo Berti; George Ibars; Xiaodong Wu; Alex Sabo; Michelle Granville; Gail Suarez; James G Schwade; Robert E Jacobson Journal: Cureus Date: 2018-05-09